Suchergebnisse - "Kraguljac, Nina Vanessa"

PubPharm (7)

1

The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - A systematic review of magnetic resonance spectroscopy studies

enthalten in: Schizophrenia research | 2022

von Reddy-Thootkur, M. | Kraguljac, N. | Lahti, A.

2

White Matter Neurometabolic Signatures Support the Deficit and Nondeficit Distinction in Antipsychotic-Naïve First-Episode Psychosis Patients

enthalten in: Schizophrenia bulletin | 2021

von Bryant, J. | Lahti, A. | Briend, F. | +1

3

Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment

enthalten in: Neuropsychobiology | 2021

von Gurler, D. | White, D. | Kraguljac, N. | +4

4

Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients

enthalten in: Translational psychiatry | 2020

von Birur, B. | Kraguljac, N. | VerHoef, L. | +5

5

Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism

enthalten in: Journal of psychiatric research | 2019

von Bryant, J. | Frölich, M. | Tran, S. | +3

6

Paving the Way for Targeted Drug Development in Schizophrenia

enthalten in: JAMA psychiatry | 2018

von Kraguljac, N. | Lahti, A.

CommentOn: JAMA Psychiatry. 2018 Jan 1;75(1):11-19. - PMID 29167877

7

Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia

enthalten in: Hippocampus | 2014

von Kraguljac, N. | White, D. | Hadley, J. | +2

1
[1]